Luiza Ghila and her team in Cell Fate Lab has been awarded funding from The Norwegian Cancer Society’s call “Researcher projects 2025” for the research project “Mapping the bladder tumour immune microenvironment by single cell technologies“. More information is found here: https://chera.w.uib.no/2025/12/grant-award-the-norwegian-cancer-society/
HUVAMER receives Funding from Trond Mohn Foundation
The Trond Mohn Foundation has newly awarded 18 millions NOK to three cancer research projects, one of which is HUVAMER-project “HUVAMER – Home Treatment for Blood Cancer” led by Professor Dr. med. Bjørn Tore Gjertsen. The HUVAMER-project is aimed to test two repurposed drug combinations (hydroxyurea + valproate, and 6-mercaptopurine + valproate) in treatment of READ MORE
The Nordic AML Group Meeting 2025 in Bergen
On September 10-12th 2025, the Nordic AML Group Meeting took its place in Bergen – Norway. The meeting was organised by the Nordic AML Group (https://www.namlg.org/) chaired by Professor Dr. med. Bjørn Tore Gjertsen. The K.G. Jebsen-Centre for Myeloid Blood Cancer (CMYC) contributed as the local organising committee, the technical organizer for the meeting, and READ MORE
Master´s degree examination
Stine Haugstvedt will present and defend her Master’s thesis: “Optimizing single-cell and immune profiling of asciminib-treated chronic myeloid leukemia patients using mass cytometry” Supervisors: Internal Examiner: Prof. Berit Johansen (NTNU)External Examiner: Dr. David Micklem (BerGenBio)
NB